Ledger.Open graph →
SEC Form D · Amendment · filed July 16, 2019

Black Diamond Therapeutics, Inc

Offering
$87.2M
Sold
$44.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Rajeev M. Shah · Stony Brook, NYDirectorFang M. Ni · Stony Brook, NYExecAlexander M. Mayweg · Cambridge, MADirectorBradley M. Bolzon · Cambridge, MADirectorRajeev M. Shah · Stony Brook, NYDirectorAli M. Behbahani · Stony Brook, NYDirectorFang M. Ni · Stony Brook, NYExecElizabeth M. Buck · Cambridge, MAExecAlexander M. Mayweg · Cambridge, MADirectorBrent E. Hatzis-Schoch · Cambridge, MAExecGarry E. Menzel · Cambridge, MADirectorBradley M. Bolzon · Stony Brook, NYDirectorDavid M. Epstein · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗